Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SF3B1 Gene Mutation”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT04278768
What this trial is testing

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Curis, Inc. 366
Not applicableNot Yet RecruitingNCT07113132
What this trial is testing

Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia ALLChronic Lymphocytic Leukemia (CLL)
Safaa Ali 84
Not applicableActive Not RecruitingNCT04447651
What this trial is testing

Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM)

Who this might be right for
Metastatic Solid TumorSF3B1 Gene MutationSpliceosome Mutation+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Early research (Phase 1)Not Yet RecruitingNCT07137637
What this trial is testing

HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed and Refractory Acute Myeloid Leukemia (RR-AML)
Hangzhou Polymed Biopharmaceuticals, Inc. 60